| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 03/03/2011 | US20110053858 Heterocyclic peptide ketoamides |
| 03/03/2011 | US20110052643 Compounds for inflammation and immune-related uses |
| 03/03/2011 | US20110052589 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
| 03/03/2011 | US20110049495 Quinoxaline derivatives and organic light-emitting diodes comprising the same |
| 03/02/2011 | EP2289882A1 3-oxopiperazinium derivatives as agonists of nerve growth factor and their use as medicaments |
| 03/02/2011 | EP2289518A1 Therapeutic agent for inflammatory bowel disease |
| 03/02/2011 | EP2288594A1 Imidazolidine derivatives |
| 03/02/2011 | EP1001945B1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56lck TYROSINE KINASES |
| 03/01/2011 | US7897764 Thiourea derivatives |
| 02/24/2011 | US20110046376 Methods for synthesizing heterocyclic compounds. |
| 02/24/2011 | US20110046373 Succinic acid diester derivative, process for production thereof, and use of the derivative in the production of pharmaceutical preparation |
| 02/24/2011 | US20110046159 Arylpyrazinone derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 02/24/2011 | US20110046158 Capped pyrazinoylguanidine sodium channel blockers |
| 02/24/2011 | US20110046147 17beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of hormone-related diseases |
| 02/24/2011 | US20110046146 Phosphodiesterase 4 inhibitors |
| 02/24/2011 | US20110046139 Benzocycloheptane and benzoxepine derivatives |
| 02/24/2011 | US20110046135 New compounds i |
| 02/24/2011 | US20110046128 Novel compounds advantageous in the treatment of central nervous system diseases and disorders |
| 02/24/2011 | US20110046112 Novel bicyclic sulfonamide derivatives which are l-cpt1 inhibitors |
| 02/24/2011 | US20110046106 Aryl sulfonamides as effective analgesics |
| 02/24/2011 | US20110044899 Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors |
| 02/23/2011 | EP2285786A1 Quinoxalinedione derivatives |
| 02/23/2011 | EP2285785A1 3,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of arway diseases |
| 02/23/2011 | EP2035401B1 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics |
| 02/23/2011 | CN1882549B 7-phenylalkyl substituted 2-quinolinones and 2 quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 02/23/2011 | CN101981015A 3-trifluoromethyl-pyrazine-2-carboxylic acid amide derivatives as HDL-cholesterol raising agents |
| 02/23/2011 | CN101981010A 酰胺化合物 Amide compounds |
| 02/23/2011 | CN101981003A Amide compounds, compositions and uses thereof |
| 02/23/2011 | CN101979394A A method to inhibit ethylene responses in plants |
| 02/23/2011 | CN100999502B Process of selectively synthesizing 5-methyl pyrazine-2-carboxylic acid using 2,5-dimethyl pyrazine |
| 02/22/2011 | US7893263 Structural analogs of corosolic acid having anti-diabetic and anti-inflammatory properties |
| 02/22/2011 | US7893085 3-(4-Bromo-2-fluoro-phenylamino)-thieno[3,2-c]pyridine-2-carboxylic acid (2,2-dimethyl-[1,3]dioxolan-4-ylmethoxy)-amide; mitogen activated protein extracellular kinase kinase (MEK) inhibitor; antiproliferative, antiinflammatory agent |
| 02/22/2011 | CA2580541C An improved electrochromic medium capable of producing a pre-selected color |
| 02/22/2011 | CA2476296C Amino-derivatives as inhibitors of histone deacetylase |
| 02/22/2011 | CA2403139C Novel 1-[1-(hetero)aryl-1-perhydroxyalkylmethyl]-piperazine compounds, process for their preparation and medicaments containing these compounds |
| 02/22/2011 | CA2350882C Transfection reagents |
| 02/22/2011 | CA2328438C Heterocyclically substituted amides, their production and their use |
| 02/22/2011 | CA2319198C Substituted oxoazaheterocyclyl factor xa inhibitors |
| 02/17/2011 | WO2011018994A1 Phthalocyanine compound, preparation method therefor, and coloring composition including said phthalocyanine compound |
| 02/17/2011 | WO2010123959A3 2,5-disubstituted arylsulfonamide ccr3 antagonists |
| 02/17/2011 | US20110040092 process for making and using hof.rcn |
| 02/17/2011 | US20110040091 Process for the preparation of (r)-2-phenyl propionic acid derivatives |
| 02/17/2011 | US20110039860 Soluble epoxide hydrolase inhibitors, compositions containing such compounds and methods of treatment |
| 02/17/2011 | US20110039841 Novel compounds, their preparation and use |
| 02/17/2011 | US20110039819 Substituted phenoxybenzamides |
| 02/17/2011 | US20110039802 Npy y5 antagonist |
| 02/17/2011 | DE112009000527T5 Hydroxyapatit mit auf dessen Oberfläche befindlichem Silber Hydroxyapatite with befindlichem on the surface of silver |
| 02/16/2011 | EP2284152A2 Substituted tetracycline compounds |
| 02/16/2011 | EP2282999A1 Amino-quinoxaline and amino-quinoline compounds for use as adenosine a2a receptor antagonists |
| 02/16/2011 | EP2282995A1 Derivatives of quinolines and quinoxalines as protein tyrosine kinase inhibitors |
| 02/16/2011 | EP1379498B1 Sulphones which modulate the action of gamma secretase |
| 02/16/2011 | CN101973946A Phenazine-1-carboxylic acids derivative and preparation method thereof |
| 02/16/2011 | CN101973945A Synthesis method of tetraarylpyrazine compounds |
| 02/16/2011 | CN101486686B Two compounds with quinoxaline mother ring and preparation thereof |
| 02/16/2011 | CN101333195B Method for harnessing and recovering producing waste water of cyadox |
| 02/16/2011 | CN101023064B Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors |
| 02/15/2011 | US7888506 Composition, synthesis, and use of a new class of fluorophores |
| 02/15/2011 | US7888359 Cyclohexyl or piperidinyl carboxamide antibiotic derivatives |
| 02/15/2011 | US7888355 Compositions and methods for inhibiting growth and metastasis of melanoma |
| 02/15/2011 | US7888351 Organic compounds |
| 02/15/2011 | CA2481460C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics |
| 02/15/2011 | CA2478156C Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 02/10/2011 | US20110033411 Novel Ammonium-Polyurethane- And/Or Polycarbonate Compounds |
| 02/09/2011 | EP1831184B1 Pyrazines and pyridines and derivatives thereof as therapeutic compounds |
| 02/09/2011 | EP1689715B1 Tubulin inhibitors |
| 02/09/2011 | EP1644321B1 New benzamides as ppaty modulators |
| 02/09/2011 | CN101970418A Novel compounds, use and preparation thereof |
| 02/09/2011 | CN101970417A Substituted pyraz inylmethyl sulfonamides for use as. fungicides |
| 02/09/2011 | CN101970409A Uv-filter compounds |
| 02/09/2011 | CN101168530B 1,4-dioxoquinoxaline formaldehyde dihydrazone with weed control activity and its preparation method and application |
| 02/08/2011 | US7884097 Methods and compositions comprising diamines as new anti-tubercular therapeutics |
| 02/08/2011 | CA2479906C Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors |
| 02/03/2011 | US20110028721 Chromophore and Polymer Capable of Detecting the Presence of Various Neurotoxins and Method of Use |
| 02/03/2011 | US20110028489 Pyrimidine Derivatives and Their Use for Treating Bone-Related Disorders |
| 02/03/2011 | CA2769408A1 Apaf-1 inhibitor compounds |
| 02/02/2011 | EP2280021A1 Pharmaceutical formulations comprising insulin complexed with a diketopiperazine |
| 02/02/2011 | EP2280020A1 Pharmaceutical formulations comprising a peptide complexed with a diketopiperazine |
| 02/02/2011 | EP2280004A1 Pharmaceutique formulations comprising insulin complexed with a diketopiperazine |
| 02/02/2011 | EP2279179A2 Phenyl piperazine compounds, pharmaceutical composition including the same, and use thereof |
| 02/02/2011 | CN101519379B Method for preparing 5-methylprazine-2-carboxylic acid |
| 02/01/2011 | US7880001 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme |
| 02/01/2011 | US7879857 6-substituted 2-quinolinones and 2-quinoxalinones as poly (adp-ribose) polymerase inhibitors |
| 02/01/2011 | US7879838 Heteroaryl substituted pyrazinyl-piperazine-piperidines with CXCR3 antagonist activity |
| 02/01/2011 | CA2461218C Muscarinic agonists |
| 01/27/2011 | WO2011010619A1 Diamine compound, polyamic acid, polyimide, and liquid crystal aligning agent |
| 01/27/2011 | US20110021538 Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
| 01/27/2011 | US20110021533 Cysteine prodrugs to treat schizophrenia and drug addiction |
| 01/27/2011 | US20110021528 Novel hydroxamates as therapeutic agents |
| 01/27/2011 | US20110021523 Aryl sulfonamides |
| 01/27/2011 | US20110021506 Anthelmintic agents and their use |
| 01/26/2011 | EP2277865A1 Phenyl-substituted 6-ring nitrogen-heterocycles as microtubule polymerisation inhibitors |
| 01/26/2011 | EP2276748A1 Bicyclic nitrogen containing heterocyclic compounds for use as stearoyl coa desaturase inhibitors |
| 01/26/2011 | CN1726603B Charge transport compositions and electronic devices made with such compositions |
| 01/26/2011 | CN101959868A Fibrosis inhibitor |
| 01/26/2011 | CN101955467A Preparation method of 2, 3, 5-trimethylpyrazine |
| 01/26/2011 | CN101077875B Boronic ester and acid compounds, synthesis and uses |
| 01/25/2011 | US7875619 Hetero substituted sodium channel blockers |
| 01/25/2011 | CA2368849C Process for preparing amine platinum complexes |
| 01/20/2011 | US20110015211 Fibrosis inhibitor |
| 01/20/2011 | US20110015210 Pyrazinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |